• I-BET-762: BET Inhibitor Workflows for Ferroptosis and Infla

  2026-04-22

  I-BET-762 delivers potent, selective BET inhibition for dissecting transcriptional regulation and ferroptosis in preclinical models. This guide unpacks nuanced, evidence-backed workflows and troubleshooting tactics to maximize reproducibility and data quality using I-BET-762 from APExBIO.

• PP 2 (AG 1879): Selective Src Kinase Inhibitor for Research

  2026-04-21

  PP 2 (AG 1879) is a potent, selective inhibitor of Src family kinases, widely used in signal transduction and cancer research. Its nanomolar inhibition of Lck and Fyn enables precise dissection of Src-mediated cellular processes. Protocols, evidence, and application boundaries are detailed below.

• Tunable Human Intestinal Organoids: Balancing Renewal & Dive

  2026-04-21

  This study introduces a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The innovation enables enhanced cellular diversity and proliferative capacity in vitro, streamlining disease modeling and high-throughput applications.

• Phosbind Acrylamide: Transforming Phosphorylation Analysis

  2026-04-20

  This thought-leadership article explores the mechanistic and strategic value of Phos binding reagent (Phosbind) acrylamide for translational researchers. It contextualizes the reagent within the evolving landscape of protein phosphorylation analysis, links its utility to discoveries in viral ISR signaling, and offers guidance on experimental design, protocol optimization, and future research frontiers. By bridging recent virology findings with phosphorylation detection best practices, the article clarifies how APExBIO’s Phosbind Acrylamide advances scientific rigor and translational impact beyond conventional antibody-based workflows.

• V5 Epitope Tag Peptide: Precision Protein Tagging for Detect

  2026-04-20

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) enables precise, high-affinity protein tagging for detection and purification applications. Its robust solubility, high purity, and compatibility with immunodetection methods make it a benchmark reagent for recombinant protein research. APExBIO’s formulation (SKU A6005) ensures reproducibility and sensitivity in Western blot and immunoprecipitation workflows.

• Pemetrexed Disodium in Chemoresistance: Mechanisms and Assay

  2026-04-19

  Explore how pemetrexed disodium shapes cancer chemotherapy research by dissecting mechanisms of chemoresistance and guiding advanced assay development. This article provides a unique, evidence-driven perspective on optimizing experimental design and data interpretation.

• AP20187: Chemical Inducer of Dimerization for Precision Cont

  2026-04-18

  AP20187 stands out as a high-purity, synthetic chemical inducer of dimerization, enabling programmable regulation of gene expression and signaling in both in vitro and in vivo settings. Its robust solubility, validated performance, and compatibility with fusion protein systems position it as a key tool for conditional gene therapy and metabolic research.

• QPRT Drives Breast Cancer Invasion via Myosin Light Chain Ph

  2026-04-17

  This study identifies quinolinate phosphoribosyltransferase (QPRT) as a key promoter of breast cancer cell invasiveness through regulation of myosin light chain (MLC) phosphorylation. The findings reveal a mechanistic link between altered NAD+ metabolism in cancer and cytoskeletal dynamics, with implications for targeting metastatic pathways.

• GLI Inhibitors in Cancer: Translating Mechanisms to Therapie

  2026-04-16

  This article explores how selective GLI inhibition—exemplified by the small-molecule antagonist GANT61—unlocks new opportunities for translational cancer research. By dissecting the mechanistic role of GLI transcription factors in tumor growth, immune evasion, and resistance to immunotherapy, it provides researchers with strategic guidance for experimental planning, workflow optimization, and clinical translation. The discussion synthesizes cutting-edge findings, positions GANT61 as a pivotal tool in the evolving landscape, and delivers actionable insights supported by recent high-impact studies.

• Crystallization of DDX3 Helicase: Role of Spermine Tetrahydr

  2026-04-15

  This study reports the successful expression, purification, and crystallization of the DDX3 RNA helicase domain, a key human DEAD-box protein implicated in RNA metabolism and disease. The inclusion of spermine tetrahydrochloride was critical for obtaining high-quality protein crystals, enabling structural analysis central to understanding DDX3's biological and therapeutic roles.

• Diphenyleneiodonium Chloride: Redox Probe for cAMP Signaling

  2026-04-14

  Diphenyleneiodonium chloride (DPI) is a potent, selective inhibitor of redox enzymes and a unique modulator of cAMP signaling through GPR3 agonism. DPI enables precise dissection of NADH oxidase function and cAMP-mediated pathways, supporting advanced oxidative stress research. Its irreversible inhibition profile and dual-action mechanism underpin translational studies in cell signaling and disease modeling.

• (-)-Arctigenin: Strategic MEK1 Inhibition in Tumor Microenvi

  2026-04-13

  Explore how (-)-Arctigenin enables translational researchers to target the breast cancer microenvironment by integrating MEK1 and NF-κB pathway modulation. This article delivers actionable guidance and mechanistic insight, connecting recent evidence on TAM-derived miR-660 with protocol recommendations and workflow strategies for advanced oncology research.

• Cy5.5 NHS Ester: Advanced Fluorescent Labeling for Protein C

  2026-04-12

  Cy5.5 NHS ester (non-sulfonated) from APExBIO empowers deep-tissue and in vivo fluorescence imaging through robust protein, peptide, and oligonucleotide labeling. This article decodes stepwise protocols, advanced use-cases in tumor imaging, and practical troubleshooting tips, bridging recent research innovations with hands-on assay optimization.

• PPM-18: Precision iNOS Inhibition for Cardiovascular and Sep

  2026-04-12

  Explore how PPM-18, a potent iNOS expression inhibitor, enables advanced modulation of inflammation and cardiovascular signaling. This article provides unique insight into practical assay design, with a focus on mechanistic depth and translational relevance.

• Topotecan (SKF104864): Applied Cancer Research Workflows

  2026-04-11

  Topotecan (SKU B4982), a potent topoisomerase I inhibitor, empowers cancer researchers with reproducible, high-impact protocols for apoptosis induction and cell cycle arrest in diverse tumor models. Discover stepwise guidance, troubleshooting strategies, and comparative insights that highlight APExBIO’s Topotecan as a benchmark for translational oncology workflows.

470 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page